U.S., Oct. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07206290) titled 'Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease' on Sept. 25.
Brief Summary: The ARTIST-CKD trial is a clinical study evaluating the effect of weekly subcutaneous administration of survodutide (3.6 mg) on kidney function in patients with chronic kidney disease (CKD) and elevated albuminuria. The primary objective is to determine whether survodutide leads to early, sustained, and clinically meaningful reductions in albuminuria, regardless of diabetes status.
Study Start Date: March 02, 2026
Study Type: INTERVENTIONAL
Condition:
Chronic Kidney Disease
Intervention:
DRUG: Survodutide (BI 456906)
0.3 mg, 0...